Innovating Works

H2020

Cerrada
HORIZON-HLTH-2022-IND-13-02
Scaling up multi-party computation, data anonymisation techniques, and synthetic data generation
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 6 “Maintaining an innovative, sustainable and globally competitive health industry”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 21 al 40 de 230 resultados
BAXERNA 2.0: Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines VIB VZW tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage BAXERNA 2.0 will establish a new vaccine development pipeline based on dramatically improved immunopeptidomics screening and innovative mRNA...
2023-07-01 - 2028-06-30 | Financiado
METASTRA: COMPUTER-AIDED EFFECTIVE FRACTURE RISK STRATIFICATION OF PATIENTS WITH VERTEBRAL METASTASES FOR PERS... ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Cancer patients (2.7M in Europe) with a positive prognosis are exposed to a high incidence of secondary tumours (≈1M). Bone metastases sprea...
2023-07-01 - 2028-06-30 | Financiado
OptiViVax: Optimising a High Efficacy Plasmodium vivax Malaria Vaccine STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Plasmodium vivax is the most widespread human malaria with 2.5 billion people living at risk in South America, Oceania and Asia. The revised...
2023-06-01 - 2028-05-31 | Financiado
STRATIFYHF: Artificial intelligence-based decision support system for risk stratification and early detection of... ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Heart failure (HF) is a pandemic currently affecting up to 15 million people in Europe. It is a complex clinical syndrome presenting with im...
2023-06-01 - 2027-05-31 | Financiado
RECONNECTED: A complex systems approach towards REsilient and CONNECTED vulnerable European communities in times... STICHTING VU tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Europe is facing a number of global challenges such as digitalisation, migration, and climate change which increase demands on citizens’ res...
2023-06-01 - 2027-11-30 | Financiado
FLUniversal: Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses Zafiro Business Solutions Korlatolt Felelossegu Tarsasag tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage "Researchers worldwide have been working to develop a universal flu vaccine, but no breakthrough has yet been achieved. FLUniversal is not "...
2023-06-01 - 2027-05-31 | Financiado
SHIFT2HEALTH: Development and evaluation of nutritional strategies to reduce and prevent obesity in shift workers UNIVERSITAT WIEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Shift work is an independent risk factor for the development of overweight and obesity. As shift workers represent a huge target group throu...
2023-06-01 - 2028-05-31 | Financiado
EURAS: EUropean network for neurodevelopmental RASopathies UNIVERSITATSKLINIKUM ERLANGEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Cardio-facio-cutaneous syndrome, Costello syndrome and SYNGAP1-related encephalopathy are rare neurodevelopmental RASopathies manifesting wi...
2023-06-01 - 2027-05-31 | Financiado
AI4HF: Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure STICHTING NETHERLANDS HEART INSTITUTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Cardiovascular diseases remain the main cause of mortality worldwide; in particular, heart failure (HF) poses complex challenges in clinical...
2023-06-01 - 2027-05-31 | Financiado
PREPARE: PERSONALIZED REHABILITATION VIA NOVEL AI PATIENT STRATIFICATION STRATEGIES ARISTOTELIO PANEPISTIMIO THESSALONIKIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage PREPARE aims at advancing rehabilitation care for patients with chronic non-communicable diseases. As rehabilitation is a complex, multiface...
2023-06-01 - 2027-05-31 | Financiado
TiilT: Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites SORBONNE UNIVERSITE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage As major players in the regulation of immune responses, regulatory T cells (Tregs) are important therapeutic targets for autoimmune and infl...
2023-06-01 - 2028-05-31 | Financiado
Recon4IMD: Reconstruction and Computational Modelling for Inherited Metabolic Diseases UNIVERSITY OF GALWAY tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Establis...
2023-06-01 - 2027-05-31 | Financiado
MAGIC: Next-generation models and genetic therapies for rare neuromuscular diseases INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Muscular dystrophies are severe genetic disorders characterised by muscle wasting, impaired mobility and premature death, which to date rema...
2023-06-01 - 2027-05-31 | Financiado
ITHEMYC: Novel immunotherapies for tuberculosis and other mycobacterial diseases STICHTING TUBERCULOSIS VACCINE INITIATIVE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Tuberculosis (TB) remains the leading cause of death due to a single pathogen, Mycobacterium tuberculosis (Mtb; except in 2020-2022, when it...
2023-06-01 - 2027-05-31 | Financiado
BIO-STREAMS: Multi-Pillar Framework for children Anti-Obesity Behavior building on an EU biobank, Micro Moments a... EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLOGISTON tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage During the last decades, overweight & obesity rates have reached epidemic proportions across EU. Prevalence in childhood is particularly ala...
2023-05-01 - 2027-04-30 | Financiado
PLACES: PLAsticity of perception in real and virtual spaCES UNIVERSITAET MUENSTER tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Space is fundamental to physical and perceptual reality, but physical and perceptual space are not the same. Perceptual space is created by...
2023-05-01 - 2027-04-30 | Financiado
HealthyW8: Empowering healthy lifestyle behaviour through personalised intervention portfolios to prevent and c... LUXEMBOURG INSTITUTE OF HEALTH tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Over 30% of EU citizens at vulnerable stages and situations in life are at increased risk to transgress from healthy weight to overweight an...
2023-05-01 - 2028-04-30 | Financiado
CoMPaSS-NMD: Computational Models for new Patients Stratification Strategies of Neuromuscular Disorders UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage The CoMPaSS-NMD project creates novel and universal tools for the diagnostic stratification of patients suffering from Hereditary NeuroMuscu...
2023-05-01 - 2027-04-30 | Financiado
RESTORE VISION: Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular s... UNIVERSITY OF GALWAY tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Rare Eye Diseases (REDs) are a major cause of visual impairment and blindness in Europe, affecting patients of all ages. The RESTORE VISION...
2023-05-01 - 2027-04-30 | Financiado
PAS GRAS: DE-RISKING METABOLIC, ENVIRONMENTAL AND BEHAVIORAL DETERMINANTS OF OBESITY IN CHILDREN, ADOLESCENTS... UNIVERSIDADE DE COIMBRA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage PAS GRAS aims to prevent and reverse obesity and associated metabolic complications in four age groups: pre-pubertal children (3-9 yr), adol...
2023-05-01 - 2028-04-30 | Financiado